Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

How green biotech turned white and blue

Argentina has blazed a trail as one of the leading genetically modified (GM) crop producers. Can other developing countries import the seeds of its success? Lucas Laursen investigates.

This is a preview of subscription content

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

Figure 1: GM plant field trial approvals in Argentina.

References

  1. Newell, P. J. Latin Amer. Studies 41, 27–57 (2009).

    Article  Google Scholar 

  2. http://www.monsanto.com/pdf/pubs/2009/annual_report.pdf

  3. Silva, J.F. Brazil Biotechnology Annual Agricultural Biotechnology Report 2008 (US Department of Agriculture FAS, Brasilia, 2008) http://www.fas.usda.gov/gainfiles/200807/146295139.pdf

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Laursen, L. How green biotech turned white and blue. Nat Biotechnol 28, 393–395 (2010). https://doi.org/10.1038/nbt0510-393

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0510-393

Further reading

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing